Press releasePRNewswire
CH4 Natural Solutions
MTNE · NYSE
$9.92+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
About MTNE
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- May 1, 2026
- Sector
- N/A
- Industry
- N/A
- Website
- mtne.co
MTNE key statistics
- Market cap
- 292.97M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 7.58K
- Volume
- 24.83K
- Open price
- $9.90
- High today
- $9.92
- Low today
- $9.92
- 52 Week high
- $10.05
- 52 Week low
- $9.84
CH4 Natural Solutions (MTNE) at a glance
As of Oct 29, 2026, CH4 Natural Solutions (MTNE) shares are priced at $9.92, giving the company a market cap of 292.97M and a price-to-earnings ratio of 0.00.
Volume so far is 24.83K shares, above the average of 7.58K shares a day.
Over the past year CH4 Natural Solutions has ranged from $9.84 to $10.05, and now sits 38% of the way up that range.
MTNE news
- Press releasePRNewswire
CH4 Natural Solutions Corporation Announces Pricing of Initial Public Offering
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.